YLYingrui Liu

Yingrui Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yingrui Liu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Kevin Zhang

    F.M. Kirby Center for Molecular Ophthalmology Scheie Eye Institute Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

    3 shared publications
  • Ying Song

    F.M. Kirby Center for Molecular Ophthalmology Scheie Eye Institute Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

    3 shared publications
  • Brent A. Bell

    F.M. Kirby Center for Molecular Ophthalmology Scheie Eye Institute Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

    2 shared publications
  • Jacob K. Sterling

    F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, 422 Curie Blvd, Philadelphia, PA, USA

    2 shared publications
  • Joshua L. Dunaief

    FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA

    2 shared publications
  • Aditya Rao

    Department of Molecular Life Science University of Pennsylvania Philadelphia Pennsylvania USA

    1 shared publication

Latest Publications

  • Open Access

    Deuterated docosahexaenoic acid protects against oxidative stress and geographic atrophy‐like retinal degeneration in a mouse model with iron overload

    by Yingrui Liu, Brent A. Bell, Ying Song, Kevin Zhang, Brandon Anderson, Paul H. Axelsen, Whitney Bohannan, Martin‐Paul Agbaga, Hui Gyu Park, Genevieve James, et al.

    Oxidative stress plays a central role in age‐related macular degeneration (AMD). Iron, a potent generator of hydroxyl radicals through the Fenton reaction, has been implicated in AMD. One easily oxidized molecule is docosahexaenoic acid (DHA), the most abundant polyunsaturated fatty acid in photoreceptor membranes. Oxidation of DHA produces toxic oxidation products including carboxyethylpyrrole (CEP) adducts, which are increased in the retinas of AMD patients. In this study, we hypothesized that deuterium substitution on the bis‐allylic sites of DHA in photoreceptor membranes could prevent iron‐induced retinal degeneration by inhibiting oxidative stress and lipid peroxidation. Mice were fed with either DHA deuterated at the oxidation‐prone positions (D‐DHA) or control natural DHA and then given an intravitreal injection of iron or control saline. Orally administered D‐DHA caused a dose‐dependent increase in D‐DHA levels in the neural retina and retinal pigment epithelium (RPE) as measured by mass spectrometry. At 1 week after iron injection, D‐DHA provided nearly complete protection against iron‐induced retinal autofluorescence and retinal degeneration, as determined by in vivo imaging, electroretinography, and histology. Iron injection resulted in carboxyethylpyrrole conjugate immunoreactivity in photoreceptors and RPE in mice fed with natural DHA but not D‐DHA. Quantitative PCR results were consistent with iron‐induced oxidative stress, inflammation, and retinal cell death in mice fed with natural DHA but not D‐DHA. Taken together, our findings suggest that DHA oxidation is central to the pathogenesis of iron‐induced retinal degeneration. They also provide preclinical evidence that dosing with D‐DHA could be a viable therapeutic strategy for retinal diseases involving oxidative stress.


  • Minimal effect of conditional ferroportin KO in the neural retina implicates ferrous iron in retinal iron overload and degeneration

    by Yingrui Liu, Bailey Baumann, Ying Song, Kevin Zhang, Jacob K. Sterling, Samira Lakhal-Littleton, Zbynek Kozmik, Guanfang Su, Joshua L. Dunaief


  • Open Access

    Intraocular iron injection induces oxidative stress followed by elements of geographic atrophy and sympathetic ophthalmia

    by Yingrui Liu, Brent A. Bell, Ying Song, Hye J. Kim, Jacob K. Sterling, Benjamin J. Kim, Maura Poli, Michelle Guo, Kevin Zhang, Aditya Rao, et al.

    Iron has been implicated in the pathogenesis of age‐related retinal diseases, including age‐related macular degeneration (AMD). Previous work showed that intravitreal (IVT) injection of iron induces acute photoreceptor death, lipid peroxidation, and autofluorescence (AF). Herein, we extend this work, finding surprising chronic features of the model: geographic atrophy and sympathetic ophthalmia. We provide new mechanistic insights derived from focal AF in the photoreceptors, quantification of bisretinoids, and localization of carboxyethyl pyrrole, an oxidized adduct of docosahexaenoic acid associated with AMD. In mice given IVT ferric ammonium citrate (FAC), RPE died in patches that slowly expanded at their borders, like human geographic atrophy. There was green AF in the photoreceptor ellipsoid, a mitochondria‐rich region, 4 h after injection, followed later by gold AF in rod outer segments, RPE and subretinal myeloid cells. The green AF signature is consistent with flavin adenine dinucleotide, while measured increases in the bisretinoid all‐trans‐retinal dimer are consistent with the gold AF. FAC induced formation carboxyethyl pyrrole accumulation first in photoreceptors, then in RPE and myeloid cells. Quantitative PCR on neural retina and RPE indicated antioxidant upregulation and inflammation. Unexpectedly, reminiscent of sympathetic ophthalmia, autofluorescent myeloid cells containing abundant iron infiltrated the saline‐injected fellow eyes only if the contralateral eye had received IVT FAC. These findings provide mechanistic insights into the potential toxicity caused by AMD‐associated retinal iron accumulation. The mouse model will be useful for testing antioxidants, iron chelators, ferroptosis inhibitors, anti‐inflammatory medications, and choroidal neovascularization inhibitors.


  • Transition zone pull‐through in Hirschsprung's disease: a tertiary hospital experience

    by Dhruva N. Ghosh, Yingrui Liu, Daniel T. Cass, Soundappan S. V. Soundappan

    Background: Pull‐through of ganglionic bowel is essential for successful treatment of Hirschsprung's disease. We studied the incidence of transition zone pull‐through in our institution and compared its outcome with ganglionic bowel pull‐through.Methods: Children who underwent Soave's pull‐through for Hirschsprung's disease from January 2005 to November 2012 were studied. Patients were divided into two groups: ganglionic bowel pull‐throughs (Group 1) and transition zone pull‐throughs (Group 2). Demographics, presentations, surgical procedure, post‐operative results and complications including redo procedures were recorded and reviewed along with histopathology reports.Results: Fifty patients underwent Soave's pull‐through for Hirschsprung's disease in our group. The median age at surgery was 13.5 days in Group 1 and 22.5 days in Group 2. Transition zone pull‐through occurred in eight children (16%). Transition zone pull‐through was attributed to errors in histologic interpretation (n = 5), sampling (n = 2) and surgical technique (n = 1). The transition zone was significantly longer in Group 2 (P = 0.002). Constipation and enterocolitis were the main complications needing therapy. One child in Group 2 required surgery for adhesive intestinal obstruction.Conclusions: The length of the transition zone in children with transition zone pull‐through was significantly longer. Though our children with transition zone pull‐through did not require redo surgery the possibility of redo surgery remains. Transition zone pull‐through should still be considered an error and should be prevented.